Tag Archives: quest diagnostics

November, 2018

2 November
Clinical Genomics and Quest Diagnostics Extend Collaboration to Provide InSure ONE for Colorectal Cancer Screening

BRIDGEWATER, N.J., and SECAUCUS, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) — Clinical Genomics, a leading innovator of tests for colorectal cancer, and Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced a 5-year extension to their U.S. supply agreement for the InSure® ONE™ fecal immunochemical test …
Share

27 September
Quest Diagnostics Acquires PhenoPath, Broadening Access to Advanced Diagnostics

SECAUCUS, N.J. and SEATTLE, Sept. 27, 2018 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has acquired PhenoPath, a national provider of specialized anatomic pathology (AP) and related services. Based in Seattle, PhenoPath provides AP, molecular oncology and other services that complement and extend those of …
Share

24 May
Quest Diagnostics Study Finds Physicians Lack the Time and Tools to Discover Hidden Risks in Patients with Chronic Conditions

SECAUCUS, N.J., May 23, 2018 /PRNewswire/ — The vast majority of primary care physicians don’t have the time or tools to adequately address the needs of their patients with multiple chronic conditions, leaving some patients to struggle with health-related social and behavioral issues on their own, according to new research …
Share

25 January
Quest Diagnostics to Acquire MedXM, Expanding its Health Risk Assessment Services to Close Gaps in Care

SECAUCUS, N.J., Jan. 23, 2018 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced it has formed a definitive agreement to acquire Mobile Medical Examination Service (MedXM), a leading national provider of home-based health risk assessments and related services. The acquisition will expand …
Share

18 January
Quest Diagnostics Launches New HBV Test to Help Assess Response to Antiviral Therapy

MADISON, N.J., Jan. 18, 2017 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced the launch of a new test service that helps physicians evaluate a patient’s response to drug therapies used to treat infection with the hepatitis B virus (HBV). The first …
Share

29 April
FDA Authorizes Quest’s Zika Test for Emergency Use

MADISON, N.J., April 28, 2016 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has received a U.S. Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for the Zika Virus RNA Qualitative Real-Time RT-PCR test (Zika RT-PCR test). The test …
Share

9 October
Quest Diagnostics Presents Study Demonstrating Clinical Value in Genetic Tests for Predicting Disease

MADISON, N.J., Oct. 8, 2015 /PRNewswire/ — Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics (ASHG) Annual Meeting, which runs …
Share

22 April
Quest Diagnostics Joins French Agency to Launch BRCA Gene Datasharing Initiative

US-based Quest Diagnostics has teamed up with Inserm, the French National Institute of Health and Medical Research institution, to launch an expanded database for BRCA1 and BRCA2 genetic data. The initiative, called BRCA Share, was co-founded by Quest and Inserm to provide scientists and laboratory organizations around the world open …
Share
9 April
Quest Diagnostics Announces the Launch of New Technology Solutions

Quest Diagnostics announced that it will unveil a suite of new technology solutions, featuring interactive Insights by Care360 reports and IntelliTest Analytics. The leading provider of diagnostics information services said that it will launch its new technology solutions during the HIMSS 2015 Annual Conference & Exhibition, the industry’s largest health …
Share

10 March
Quest Diagnostics Announces Availability of Exclusive Whole Exome Sequencing Service for Diagnosis of Pediatric Neurological Disorders

Quest Diagnostics announced that it is now offering a whole exome sequencing service aimed to enhance the diagnosis of rare neurological disorders in pediatric population. The leading provider of diagnostic information services today announced the availability of Neurome, a whole exome sequencing service. Leading genomics-based diagnostic laboratory, Personalis, Inc. developed …
Share

Page 1 of 212 »